CorMedix Inc (NASDAQ: CRMD) closed the day trading at $5.28 up 11.16% from the previous closing price of $4.75. In other words, the price has increased by $+0.53 from its previous closing price. On the day, 1489887 shares were traded.
Ratios:
For a better understanding of CRMD, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.78 and its Current Ratio is at 6.97. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, RBC Capital Mkts on August 10, 2023, initiated with a Outperform rating and assigned the stock a target price of $6.
On February 17, 2021, Needham started tracking the stock assigning a Buy rating and target price of $31.
On September 29, 2020, JMP Securities started tracking the stock assigning a Mkt Outperform rating and target price of $22.JMP Securities initiated its Mkt Outperform rating on September 29, 2020, with a $22 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 13 ’24 when Todisco Joseph bought 13,561 shares for $3.74 per share. The transaction valued at 50,718 led to the insider holds 352,839 shares of the business.
DUNTON ALAN W bought 3,000 shares of CRMD for $9,900 on Dec 15 ’23. The Director now owns 15,250 shares after completing the transaction at $3.30 per share. On Dec 14 ’23, another insider, DUNTON ALAN W, who serves as the Director of the company, bought 3,000 shares for $3.45 each. As a result, the insider paid 10,350 and bolstered with 12,250 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CRMD now has a Market Capitalization of 261.16M and an Enterprise Value of 185.80M. Its current Enterprise Value per Revenue stands at 3.79k whereas that against EBITDA is -4.02.
Stock Price History:
Over the past 52 weeks, CRMD has reached a high of $6.09, while it has fallen to a 52-week low of $2.57. The 50-Day Moving Average of the stock is 3.62, while the 200-Day Moving Average is calculated to be 3.69.
Shares Statistics:
Over the past 3-months, CRMD traded about 440.22K shares per day on average, while over the past 10 days, CRMD traded about 453.16k shares per day. A total of 54.94M shares are outstanding, with a floating share count of 53.86M. Insiders hold about 2.04% of the company’s shares, while institutions hold 33.84% stake in the company. Shares short for CRMD as of Mar 15, 2024 were 7.77M with a Short Ratio of 18.73, compared to 7.73M on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 14.14% and a Short% of Float of 14.14%.
Earnings Estimates
Current recommendations for the stock of the company come from 4 analysts. On average, analysts expect EPS of -$0.28 for the current quarter, with a high estimate of -$0.25 and a low estimate of -$0.32, while EPS last year was -$0.24. The consensus estimate for the next quarter is -$0.26, with high estimates of -$0.22 and low estimates of -$0.28.
Analysts are recommending an EPS of between -$0.26 and -$1.09 for the fiscal current year, implying an average EPS of -$0.74. EPS for the following year is -$0.09, with 4 analysts recommending between $0.55 and -$0.67.
Revenue Estimates
Based on 4 analysts’ estimates, the company’s revenue will be $81.93M in the next fiscal year. The high estimate is $105.75M and the low estimate is $66.95M. The average revenue growth estimate for next year is up 225.60% from the average revenue estimate for this year.
